We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Ductal Lavage Helps to Assess Breast Cancer Risk

By HospiMedica staff writers
Posted on 29 Nov 2001
A study has found that a new technique called ductal lavage can help women at high risk of breast cancer choose strategies to reduce their risk, according to a report in the November 7, 2001, issue of the Journal of the National Cancer Institute. The study was conducted by researchers at the University of Oklahoma (Norman, USA)

Since more than 95% of all breast cancers begin within ductal epithelial cells, those cells should show precancerous changes, or atypia, in a woman likely to develop breast cancer, say the researchers. In the new technique, an extremely thin tube is placed through a natural opening in the nipple into a milk duct. The duct is rinsed with salt water, and any cells that wash loose for microscopic exam are collected. An earlier method of obtaining cells for exam by suctioning nipple fluid (NAF) from the breast produced too few cells. The researchers used both techniques with 507 women at high risk of breast cancer.

Ductal lavage provided enough cells to examine in 78% of women, compared to only 27% of those who had the NAF technique, providing more than 100 times more cells. The researchers say the ductal lavage method was also more than three times as good at detecting abnormal cells. Women found with atypia can then seek ways to reduce their risk, such as taking the drug tamoxifen, or they may choose to have one or both breasts removed to prevent cancer from occurring.




Related Links:
Univ. of Oklahoma

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Lithotripter
Swiss LithoClast Trilogy
New
Point-Of-Care Terminal
POC-824

Latest Patient Care News

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization